An evaluation of monitoring possibilities of argatroban using rotational thromboelastometry and activated partial thromboplastin time
Background: Rotational thrombelastometry/thrombelastography with ROTEM (R) and TEG (R) is becoming available bedside in an increasing number of intensive care units, where many patients with heparin-induced thrombocytopenia (HIT) are treated. The study has been performed in an effort to find out whether ROTEM (R) could be an alternative to activated partial thromboplastin time (aPTT) when argatrob
